Changes in Lipoprotein‐Associated Phospholipase A2 Activity Predict Coronary Events and Partly Account for the Treatment Effect of Pravastatin: Results From the Long‐term Intervention with Pravastatin in Ischemic Disease Study

BACKGROUND: Lipoprotein‐associated phospholipase A2 (Lp‐PLA(2)) levels are associated with coronary heart disease (CHD) in healthy individuals and in patients who have had ischemic events. METHODS AND RESULTS: The Long‐term Intervention with Pravastatin in Ischemic Disease (LIPID) study randomized 9...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Harvey D., Simes, John, Stewart, Ralph A. H., Blankenberg, Stefan, Barnes, Elizabeth H., Marschner, Ian C., Thompson, Peter, West, Malcolm, Zeller, Tanja, Colquhoun, David M., Nestel, Paul, Keech, Anthony C., Sullivan, David R., Hunt, David, Tonkin, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835245/
https://www.ncbi.nlm.nih.gov/pubmed/24152981
http://dx.doi.org/10.1161/JAHA.113.000360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835245/
https://www.ncbi.nlm.nih.gov/pubmed/24152981
http://dx.doi.org/10.1161/JAHA.113.000360

Ejemplares similares